U.S. Venture Partners XI L.P. 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-01 1:38 pm Sale |
2022-02-25 | 13D | Edgewise Therapeutics, Inc. EWTX |
U.S. Venture Partners XI L.P. | 15,625 0.000% |
-3,473,543 (-99.55%) |
Filing |
| 2021-04-30 6:44 pm Purchase |
2021-03-30 | 13D | Edgewise Therapeutics, Inc. EWTX |
U.S. Venture Partners XI L.P. | 3,489,168 7.100% |
3,489,168 (New Position) |
Filing |